Loading...
Hospital Infection Control Challenges May Limit Near-Term Upside Yet Long-Term Potential Appears Intact
AN
AnalystLowTarget
Not Invested
Community Contributor
Published
16 Dec 25
Views
14
16 Dec
US$3.69
AnalystLowTarget's Fair Value
US$6.00
38.5% undervalued intrinsic discount1Y
40.3%7D
10.5%1Y
40.3%7D
10.5%You can edit this narrative until Dec 17 12:05 PM. Then, changes will post as Updates.
Author's Valuation
US$638.5% undervalued intrinsic discount
AnalystLowTarget Fair Value